Measured in a cell proliferation assay using Hacat cells.
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | Fibroblast growth factor 7, FGF-7, Heparin-binding growth factor 7 (HBGF-7), Keratinocyte growth factor |
| Accession | P21781 |
| Amino Acid Sequence | Cys32-Thr194 |
| Expression System | CHO |
| Molecular Weight | 24-32 kDa (Reducing) |
| Purity | >95% by SDS-PAGE & HPLC. |
| Endotoxin | <0.1EU/μg |
| Conjugation | Unconjugated |
| Tag | No Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | PBS, pH7.4 |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | ·12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
| Reference | Am J Transplant. 2021 Sep;21(9):2950-2963. |
Background
Human fibroblast growth factor 7 (FGF-7) is also known as keratinocyte growth factor (KGF). It is a secreted, heparin-binding glycoprotein of 194 amino acids that belongs to the FGF family. FGF-7 is produced exclusively by mesenchymal cells and acts in a paracrine manner on epithelial cells expressing the splice variant FGFR2-IIIb. Upon ligand binding, the receptor dimerizes and initiates downstream signaling through the MAPK/ERK, PI3K/AKT and PLCγ pathways, leading to proliferation, migration, differentiation and survival of epithelial cells. Expression of FGF-7 is strongly up-regulated after skin, lung, kidney or gastrointestinal injury by inflammatory cytokines such as IL-1 and TNF-α, making it a key mediator of wound healing and tissue repair.
Picture
Picture
Bioactivity

KGF/FGF-7 Protein, Human (Cat#UA040561) maintains lung cancer organoid growth well during multiple passages and long-term culture processes.

KGF/FGF-7 Protein, Human (Cat#UA040561) maintains bud tip progenitor organoid growth well during multiple passages and long-term culture processes.

Determined by a cell proliferation assay using 4MBr-5 cells. The expected EC50 for this effect is 3.6-8.7ng/ml.
SDS-PAGE
2μg (R: reducing condition, N: non-reducing condition).
SEC-HPLC
>95% as determined by SEC-HPLC.
